Navigation Links
Bioamber announces world's first bio-based succinic acid plant: helping to reduce dependence on fossil fuels
Date:12/16/2008

PRINCETON, NJ, Dec. 16 /PRNewswire/ - DNP Green Technology and ARD are pleased to announce that their Bioamber joint venture has obtained the necessary permits and begun construction of the world's first production plant for bio-based succinic acid. The succinic acid plant will have an annual production capacity of 2,000 metric tons and will be integrated into an existing bio-refinery located in Pomacle, France. The plant, which is being financed by ARD at a cost of US $27m, will begin production in the fall of 2009. This technological milestone represents a significant step forward for renewable, bio-based chemistry and it will help reduce the world's dependence on fossil fuels.

Bioamber's production of bio-based succinic acid can use various renewable feedstocks such as wheat, corn, sugar cane, rice, lingo-cellulose and glycerin. Succinic acid and succinate esters can be used as building blocks in a multitude of markets including biopolymers, plastics, polyesters, resins, runway deicers, non-toxic solvents and renewable fuels (as a diesel additive).

The plant demonstrates the technological breakthrough of the US Department of Energy's proprietary E. coli bacterium, which is under exclusive license to DNP Green Technology and has been optimized by Bioamber. Bioamber's fermentation technology is cost competitive with the petrochemical processes. Bioamber's revolutionary platform also offers an important environmental advantage: it consumes CO(2), as opposed to equivalent petrochemical processes that emit greenhouse gases.

"This plant will showcase our technology at a commercial scale and prove our cost competitiveness with petrochemical feedstocks", said Patrick Piot, Bioamber's General Manager. Jean Francois Huc, President of DNP Green Technology, added: "This plant clearly demonstrates that Bioamber is the world leader in bio-based succinic acid and it will assist us in our ongoing work with a variety of industry partners seeking r
'/>"/>

SOURCE DNP GREEN TECH
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. OmegaGenesis Announces Angiogenesis Application Collaboration
2. HUYA Bioscience Announces Agreement to Provide Schering-Plough With Drug Development Candidates From China
3. Banyan Biomarkers Announces Issuance of U.S. Patent for Biomarkers for Traumatic Injury
4. Osteotech Announces Stock Repurchase Program
5. Martek Announces Fourth Quarter and FY 2008 Financial Results
6. Helix BioPharma Announces Q1 2009 Financial Results
7. Neogen Announces New Share Repurchase Program
8. Nuvelo Announces Positive Results from Phase 1 Clinical Trial of NU206 in Healthy Volunteers
9. Oridion Announces Significant Medical Research to be Presented at AARC Congress
10. Proteolix Announces Positive Data From Two Ongoing Phase 2 Clinical Trials of Carfilzomib in Multiple Myeloma at the 50th Annual Meeting of the American Society of Hematology
11. Nile Therapeutics Announces Positive Results from Phase 1b Safety and Pharmacodynamics Study of CD-NP in Patients with Heart Failure
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... Dec. 17, 2014  United Therapeutics Corporation (NASDAQ: ... as well as changes to Martine Rothblatt , ... United Therapeutics announced the promotion of ... Executive Officer and David Zaccardelli , Pharm.D. to ... with these promotions, Dr. Rothblatt,s title will change from ...
(Date:12/17/2014)... FRANCISCO, Calif. , Dec. 17, 2014 /PRNewswire/ ... of a Phase 2 study evaluating the investigational ... treatment of patients with severe, chronic itch who ... standard of care, including topical steroids and antihistamines. ... percent change in Visual Analog Scale (VAS) itch ...
(Date:12/15/2014)... (PRWEB) December 15, 2014 METTLER ... inline PVM tool, ParticleView V19 with PVM ... situ probe-based particle vision and measurement tool continuously ... process conditions. ParticleView V19 then automatically prepares a ... tracking particle size and concentration changes. This compelling ...
(Date:12/15/2014)... , Dec. 15, 2014 Organovo Holdings, ... company focused on delivering breakthrough 3D bioprinting technology,  ... and collaborators of its exVive3D TM Human ... available in full commercial release on November 18, ... resulting in several awards for innovation. ...
Breaking Biology Technology:United Therapeutics Corporation Announces Executive Promotions and CEO Compensation Change 2United Therapeutics Corporation Announces Executive Promotions and CEO Compensation Change 3United Therapeutics Corporation Announces Executive Promotions and CEO Compensation Change 4Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 3Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 4New Real-Time In Situ Probe-Based Video Microscope from METTLER TOLEDO 2Organovo Celebrates a Positive 2014 Reception of its exVive3DTM Human Liver Tissue Product 2Organovo Celebrates a Positive 2014 Reception of its exVive3DTM Human Liver Tissue Product 3
... CITY, April 26, 2011 AAPC ( www.aapc.com ) ... 30, and once again lowered prices from the previous year. Prices ... "While the primary purpose of a price reduction was to ... take advantage of the significant savings," said Olga Starynskaya, coding books ...
... April 25, 2011 Auxilium Pharmaceuticals, Inc. (NASDAQ: ... the first quarter 2011 on Monday, May 9, 2011 before ... also conduct a conference call that day at 10:00 a.m. ... 2011.  The presentation slides to be used during the call ...
... the uptake of medicines and nutrients varies from person to ... Universiteit Brussel, one of the two lead researchers in the ... Treatments and doses could be determined on the basis of ... of the gut types could also lead to other medical ...
Cached Biology Technology:AAPC Lowers Prices on Medical Coding Books, Again 2Auxilium Pharmaceuticals to Announce First Quarter 2011 Results and Conduct Conference Call on Monday, May 9, 2011 2Auxilium Pharmaceuticals to Announce First Quarter 2011 Results and Conduct Conference Call on Monday, May 9, 2011 3People fall into 3 categories of gut microbiota 2
(Date:12/15/2014)... , Dec. 12, 2014 Research and ... the addition of the "Global Facial Recognition ... http://photos.prnewswire.com/prnh/20130307/600769 ... identification of individuals. Facial recognition system measures the ... nose, jaw edges, mouth, and the distance between ...
(Date:12/11/2014)... , Dec. 10, 2014  Data Sciences ... monitoring, has released a new series of digital ... preclinical toxicology researchers. M series, part of the ... collect the best possible physiologic data when incorporating ... Adding functional endpoints to toxicology studies has evolved ...
(Date:12/10/2014)... DIEGO , Dec. 9, 2014 CIE ... collaboration catalyst that provides the connective tissue that enhances ... enabling them to easily share client-level information; earned a ... to expand to organizations serving seniors aging in community ... Diego" partner on December 11 th 4-6p. ...
Breaking Biology News(10 mins):Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3New telemetry implants expected to change how large animal toxicology studies are conducted 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 3Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 4
... of a gassy chemical messenger to dilate blood vessels and ... cells so that the immune system can recognize and attack ... , Tests at Hopkins on mice with implanted colon and ... in sildenafil-treated animals, compared to mice that did not get ...
... can lead to trouble when it comes to treating ... Oct. 1 issue of The Journal of Infectious Diseases, ... infected patients with suppressed immunity represent, next to children ... says Jean-Pierre Van geertruyden, MD, MSc, lead author of ...
... breast cancer has taken on a new meaning in the ... new therapies and detection techniques, significantly improving long-term survival for ... on these successes, researchers are now harnessing what they have ... methods of prevention to reduce the total incidence of the ...
Cached Biology News:'Erectile dysfunction' drugs heighten natural anti-cancer activity 2Malaria treatment efficacy compromised in certain HIV-positive patients 2Novel vaccine shows promise against early-stage breast cancer 2
Rabbit polyclonal antibody to Glutathione-S-Transferase (GST)...
... The gold standard for automated bioresearch: ... bioanalytical applications • Based on decades ... Automated accessories designed for bioresearch • ... • Versatility, reliability and ease-of-use • ...
... a single-channel sample processing head, an 8-channel ... dispenser all in one compact, affordable product. ... tips, the Precision XS autoclavable and organic ... for transferring larger volumes. Intuitive Precision Power ...
... The gold standard for automated bioresearch: ... bioanalytical applications • Based on decades ... Automated accessories designed for bioresearch • ... • Versatility, reliability and ease-of-use • ...
Biology Products: